NUS Links:
This review, led by Dr Raghav Sundar and Dr Soon Yu Yang, show that covid-19 vaccines provide significantly lower protection in immunocompromised patients. It highlights the importance of a second dose of covid-19 vaccine and recommends administration of a third covid-19 vaccines dose to confer improved protection for immunocompromised patients.
Read more: https://doi.org/10.1136/bmj-2021-068632
Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to the buildup …
Muscle is our first line of defence against cancer. A randomised clinical trial in Singapore, led by N2CR members A/Prof …
Nasopharyngeal carcinoma (NPC) is common in South China and parts of Southeast Asia. Despite treatment, 20-30% of patients relapse within …